M. Hamblin

发表

Sequential development of myelodysplasia and acute myeloid leukemia but with no karyotypic evolution after autografting in a patient with Philadelphia positive acute lymphoblastic leukemia.

S. Singhal, J. Mehta, R. Powles, 1997, Leukemia & lymphoma.

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia.

P. Vyas, M. Copland, R. Clark, 2016, Blood advances.

Outcome of biphenotypic acute leukemia.

D. Catovsky, E. Matutes, E. Matutes, 1999, Haematologica.

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route.

D. Catovsky, E. Matutes, C. Dearden, 2011, Blood.

Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL

J. Gribben, A. Pettitt, C. Fegan, 2017, Leukemia.

High dose methyl prednisolone in refractory chronic lymphocytic leukaemia.

D. Catovsky, E. Matutes, A. Lakhani, 1999, Leukemia and Lymphoma.

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

Adam C. Champion, Jane E. Ewing, M. Elnaggar, 2021, The Lancet Respiratory Medicine.

Interferon α and zidovudine therapy in adult T‐cell leukaemia lymphoma: response and outcome in 15 patients

J. Cavenagh, E. Matutes, E. Matutes, 2001, British journal of haematology.

Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.

S. Singhal, J. Mehta, R. Powles, 1996, Bone marrow transplantation.

T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.

S. Singhal, J. Mehta, D. Catovsky, 1996, Bone marrow transplantation.

Title Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

Schuh, Stephen, Jeffrey A Jones, 2019 .

Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jeffrey A Jones, J. Byrd, U. Jaeger, 2018, Clinical lymphoma, myeloma & leukemia.

Melphalan Versus Cyclophosphamide with Total-Body Irradiation as Conditioning for Allogeneic Bone-Marrow Transplantation in 1St Remission Acute Myeloid-Leukemia

S. Singhal, J. Mehta, Jenny C. Chang, 1994 .

Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.

G. Hale, H. Waldmann, E. Davies, 1996, Bone marrow transplantation.

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

M. Drayson, E. Low, J. Dunn, 2019, The Lancet. Oncology.

Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia.

S. Singhal, J. Mehta, P. Glynne, 1996, Seminars in hematology.

Alemtuzumab Administered by Subcutaneous Route Is Less Effective Than Intravenous Route for First Line Therapy of T-Cell Prolymphocytic Leukaemia: Results of a Pilot Study (UKCLL05)

E. Matutes, C. Dearden, A. Khot, 2008 .